{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:41:26Z","timestamp":1790228486703,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.contraception.2009.03.013","type":"journal-article","created":{"date-parts":[[2009,5,10]],"date-time":"2009-05-10T08:16:30Z","timestamp":1241943390000},"page":"445-451","source":"Crossref","is-referenced-by-count":21,"title":["Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24\/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21\/7 combined oral contraceptive"],"prefix":"10.1016","volume":"80","author":[{"given":"Leena","family":"Anttila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2009.03.013_bib1","series-title":"Contraceptive technology: nineteenth revised edition","first-page":"747","article-title":"Contraceptive efficacy","author":"Trussell","year":"2007"},{"key":"10.1016\/j.contraception.2009.03.013_bib2","first-page":"11","article-title":"New advances in contraception","author":"Shvarts","year":"2002","journal-title":"Insights"},{"issue":"3 Pt 1","key":"10.1016\/j.contraception.2009.03.013_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.03.013_bib4","series-title":"Contraceptive technology, seventeenth revised edition","first-page":"405","article-title":"The pill: combined oral contraceptives","author":"Hatcher","year":"1998"},{"issue":"suppl 1","key":"10.1016\/j.contraception.2009.03.013_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01849449","article-title":"Oral contraceptives and cycle control: a critical review of the literature","volume":"8","author":"Rosenberg","year":"1992","journal-title":"Adv Contracept"},{"key":"10.1016\/j.contraception.2009.03.013_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4755-1-1","article-title":"Effectiveness and acceptability of progestogens in combined oral contraceptives \u2014 a systematic review","volume":"1","author":"Kulier","year":"2004","journal-title":"Reprod Health"},{"key":"10.1016\/j.contraception.2009.03.013_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.013_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.013_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.013_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.03.013_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/AOG.0b013e318187e1c5","article-title":"Treatment of acne using a 3-milligram drospirenone\/20-microgram ethinyl estradiol oral contraceptive administered in a 24\/4 regimen: a randomized controlled trial","volume":"112","author":"Maloney","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.03.013_bib12","article-title":"Drospirenone 3 mg\/ethinylestradiol 20 \u03bcg COC in the treatment of acne vulgaris: investigator and subject self-assessment","author":"Maloney","year":"2007"},{"key":"10.1016\/j.contraception.2009.03.013_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.contraception.2007.11.003","article-title":"Efficacy and safety of 3 mg drospirenone \/20 \u03bcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial","volume":"77","author":"Koltun","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.013_bib14","first-page":"143","article-title":"A combined oral contraceptive containing 3-mg drospirenone\/20-\u03bcg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment","volume":"82","author":"Lucky","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2009.03.013_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/00016349109007167","article-title":"Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol","volume":"70","author":"Lammers","year":"1991","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2009.03.013_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0010-7824(94)90107-4","article-title":"Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age","volume":"49","author":"Kirkman","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.013_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(86)90006-5","article-title":"The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction","volume":"34","author":"Belsey","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.013_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00024677-200605020-00005","article-title":"A comparison of the cycle control, safety, and efficacy profile of a 21-day regimen of ethinylestradiol 20 mcg and drospirenone 3 mg with a 21-day regimen of ethinylestradiol 20 mcg and desogestrel 150 mcg","volume":"5","author":"Gruber","year":"2006","journal-title":"Treat Endocrinol"},{"key":"10.1016\/j.contraception.2009.03.013_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2006.08.008","article-title":"Combined hormonal contraceptive trials: variable data collection and bleeding assessment methodologies influence study outcomes and physician perception","volume":"75","author":"Mishell","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.013_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0010-7824(97)00024-3","article-title":"A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG)","volume":"55","author":"Archer","year":"1997","journal-title":"Contraception"},{"issue":"5 Pt 2","key":"10.1016\/j.contraception.2009.03.013_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9378(99)70362-5","article-title":"Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North American Levonorgestrel Study Group (NALSG)","volume":"181","author":"Archer","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.03.013_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0010-7824(99)00097-9","article-title":"Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study","volume":"60","author":"Endrikat","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.013_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0010-7824(97)00025-5","volume":"55","author":"Endrikat","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.03.013_bib24","first-page":"176","article-title":"Reference period analysis of vaginal bleeding with triphasic oral contraceptive agents containing norethindrone or levonorgestrel: a comparison study","volume":"37","author":"Schwarz","year":"1992","journal-title":"Int J Fertil"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409001097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409001097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T01:55:17Z","timestamp":1545270917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782409001097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0010782409001097"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2009.03.013","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}